We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Bahra 1 site, where the statues were found, has been a focal point for research on ancient Stone Age societies in Arabia since 2009. Excavations at the site have given insights into the Ubaid ...
Gilead's stock has surged due to successful launches of Livdelzi for PBC and promising developments in lenacapavir for HIV prevention. Livdelzi's approval and strong market potential, combined ...
(RTTNews) - Gilead Sciences, Inc. (GILD) Tuesday said that the U.S. Food and Drug Administration or FDA has granted Breakthrough Therapy Designation to Trodelvy for the treatment of adults with ...
In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price target of $105.00. Discover top-rated stocks from ...
Gilead Sciences (GILD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...
The statue is thought to depict Septimius Severus, who ruled from 193 to 211 C.E. It had likely been part of a larger collection of sculptures from a shrine in Bubon where Roman emperors were ...
The comedy eyes have appeared on statues and murals around the city of Bend, Oregon, causing a viral sensation. "While the googly eyes placed on the various art pieces around town might give you a ...
A six-foot sphere statue called "Orb I" by Brandon Zebold also got the googly eye treatment. City of Bend Oregon Government ...
The capital of a Corinthian column unearthed at the site Photo from the Greek Ministry of Culture A marble statue of a male figure Photo from the Greek Ministry of Culture Part of a marble lion ...
Gilead Sciences said a key European regulatory committee recommended expanded approval of its seladelpar treatment for patients with primary biliary cholangitis, a chronic and progressive liver ...
Gilead Sciences has tapped Sanofi’s Dietmar Berger as its next chief medical officer in a bid to shake up its strategy at the tail end … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback